en.unionpedia.org

Jiangsu Hengrui, the Glossary

Index Jiangsu Hengrui

Jiangsu Hengrui Pharmaceuticals Company Ltd., also known as Jiangsu Hengrui, is a Chinese pharmaceutical company that manufactures and distributes various types of drug packaging materials, cancer-treating antineoplastics, cardiovascular medication, painkillers, antibiotics, and related products.[1]

Table of Contents

  1. 32 relations: Analgesic, Antiandrogen, Antibiotic, Apatinib, Autoimmune disease, Basel, Camrelizumab, Circulatory system, Drug packaging, Fuzuloparib, Hansoh Pharmaceutical, Hepatocellular carcinoma, HIV, Interleukin-17 receptor, Kinase insert domain receptor, Lianyungang, List of antineoplastic agents, Medication, Messenger RNA, Metabolic disorder, PARP inhibitor, Pharmaceutical industry, Princeton, New Jersey, Prostate cancer, Protein engineering, Psoriasis, Public company, Research and development, Rezvilutamide, Shanghai Stock Exchange, Sun Piaoyang, Type 2 diabetes.

  2. Companies based in Jiangsu
  3. Companies in the FTSE China A50 Index
  4. Companies in the SSE 50 Index
  5. Pharmaceutical companies established in 1997
  6. Pharmaceutical companies of China

Analgesic

An analgesic drug, also called simply an analgesic, antalgic, pain reliever, or painkiller, is any member of the group of drugs used for pain management.

See Jiangsu Hengrui and Analgesic

Antiandrogen

Antiandrogens, also known as androgen antagonists or testosterone blockers, are a class of drugs that prevent androgens like testosterone and dihydrotestosterone (DHT) from mediating their biological effects in the body.

See Jiangsu Hengrui and Antiandrogen

Antibiotic

An antibiotic is a type of antimicrobial substance active against bacteria.

See Jiangsu Hengrui and Antibiotic

Apatinib

Apatinib, also known as rivoceranib, is a tyrosine kinase inhibitor that selectively inhibits the vascular endothelial growth factor receptor-2 (VEGFR2, also known as KDR).

See Jiangsu Hengrui and Apatinib

Autoimmune disease

An autoimmune disease is a condition that results from an anomalous response of the adaptive immune system, wherein it mistakenly targets and attacks healthy, functioning parts of the body as if they were foreign organisms.

See Jiangsu Hengrui and Autoimmune disease

Basel

Basel, also known as Basle,Bâle; Basilea; Basileia; other Basilea.

See Jiangsu Hengrui and Basel

Camrelizumab

Camrelizumab (SHR-1210) (INN) is an anti-PD-1 immune checkpoint inhibitor that is being investigated for hepatocellular carcinoma and Hodgkin lymphoma.

See Jiangsu Hengrui and Camrelizumab

Circulatory system

The circulatory system is a system of organs that includes the heart, blood vessels, and blood which is circulated throughout the entire body of a human or other vertebrate.

See Jiangsu Hengrui and Circulatory system

Drug packaging

Drug packaging (or pharmaceutical packaging) is process of packing pharmaceutical preparations for distribution, and the physical packaging in which they are stored.

See Jiangsu Hengrui and Drug packaging

Fuzuloparib

Fuzuloparib (trade name AiRuiYi) is a pharmaceutical drug for the treatment of ovarian cancer.

See Jiangsu Hengrui and Fuzuloparib

Hansoh Pharmaceutical

Hansoh Pharmaceutical Group Company Limited is a pharmaceutical company that manufactures and sells various types of medicine in mainland China. Jiangsu Hengrui and Hansoh Pharmaceutical are Civilian-run enterprises of China and pharmaceutical companies of China.

See Jiangsu Hengrui and Hansoh Pharmaceutical

Hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer in adults and is currently the most common cause of death in people with cirrhosis.

See Jiangsu Hengrui and Hepatocellular carcinoma

HIV

The human immunodeficiency viruses (HIV) are two species of Lentivirus (a subgroup of retrovirus) that infect humans.

See Jiangsu Hengrui and HIV

Interleukin-17 receptor

Interleukin-17 receptor (IL-17R) is a cytokine receptor which belongs to new subfamily of receptors binding proinflammatory cytokine interleukin 17A, a member of IL-17 family ligands produced by T helper 17 cells (Th17).

See Jiangsu Hengrui and Interleukin-17 receptor

Kinase insert domain receptor

Kinase insert domain receptor (KDR, a type IV receptor tyrosine kinase) also known as vascular endothelial growth factor receptor 2 (VEGFR-2) is a VEGF receptor.

See Jiangsu Hengrui and Kinase insert domain receptor

Lianyungang

Lianyungang is a prefecture-level city in northeastern Jiangsu province, China.

See Jiangsu Hengrui and Lianyungang

List of antineoplastic agents

This is a list of antineoplastic agents used to treat cancer.

See Jiangsu Hengrui and List of antineoplastic agents

Medication

A medication (also called medicament, medicine, pharmaceutical drug, medicinal drug or simply drug) is a drug used to diagnose, cure, treat, or prevent disease.

See Jiangsu Hengrui and Medication

Messenger RNA

In molecular biology, messenger ribonucleic acid (mRNA) is a single-stranded molecule of RNA that corresponds to the genetic sequence of a gene, and is read by a ribosome in the process of synthesizing a protein.

See Jiangsu Hengrui and Messenger RNA

A metabolic disorder is a disorder that negatively alters the body's processing and distribution of macronutrients, such as proteins, fats, and carbohydrates.

See Jiangsu Hengrui and Metabolic disorder

PARP inhibitor

PARP inhibitors are a group of pharmacological inhibitors of the enzyme poly ADP ribose polymerase (PARP).

See Jiangsu Hengrui and PARP inhibitor

Pharmaceutical industry

The pharmaceutical industry is an industry involved in medicine that discovers, develops, produces, and markets pharmaceutical goods for use as drugs that function by being administered to (or self-administered by) patients using such medications with the goal of curing and/or preventing disease (as well as possibly alleviating symptoms of illness and/or injury).

See Jiangsu Hengrui and Pharmaceutical industry

Princeton, New Jersey

Princeton is a borough in Mercer County, in the U.S. state of New Jersey.

See Jiangsu Hengrui and Princeton, New Jersey

Prostate cancer

Prostate cancer is the uncontrolled growth of cells in the prostate, a gland in the male reproductive system below the bladder.

See Jiangsu Hengrui and Prostate cancer

Protein engineering

Protein engineering is the process of developing useful or valuable proteins through the design and production of unnatural polypeptides, often by altering amino acid sequences found in nature.

See Jiangsu Hengrui and Protein engineering

Psoriasis

Psoriasis is a long-lasting, noncontagious autoimmune disease characterized by patches of abnormal skin.

See Jiangsu Hengrui and Psoriasis

Public company

A public company is a company whose ownership is organized via shares of stock which are intended to be freely traded on a stock exchange or in over-the-counter markets.

See Jiangsu Hengrui and Public company

Research and development

Research and development (R&D or R+D; also known in Europe as research and technological development or RTD) is the set of innovative activities undertaken by corporations or governments in developing new services or products and carrier science computer marketplace e-commerce, copy center and service maintenance troubleshooting software, hardware improving existing ones.

See Jiangsu Hengrui and Research and development

Rezvilutamide

Rezvilutamide, sold under the brand name Ariane, is a nonsteroidal antiandrogen which is approved for the treatment of prostate cancer in China and is or was under development for the treatment of breast cancer.

See Jiangsu Hengrui and Rezvilutamide

Shanghai Stock Exchange

The Shanghai Stock Exchange (SSE) is a stock exchange based in the city of Shanghai, China.

See Jiangsu Hengrui and Shanghai Stock Exchange

Sun Piaoyang

Sun Piaoyang (born 1958) is a Chinese pharmaceutical executive and billionaire, the chairman of Jiangsu Hengrui Medicine.

See Jiangsu Hengrui and Sun Piaoyang

Type 2 diabetes

Type 2 diabetes (T2D), formerly known as adult-onset diabetes, is a form of diabetes mellitus that is characterized by high blood sugar, insulin resistance, and relative lack of insulin.

See Jiangsu Hengrui and Type 2 diabetes

See also

Companies based in Jiangsu

Companies in the FTSE China A50 Index

Companies in the SSE 50 Index

Pharmaceutical companies established in 1997

Pharmaceutical companies of China

References

[1] https://en.wikipedia.org/wiki/Jiangsu_Hengrui

Also known as Hengrui Medicine, Jiangsu Hengrui Medicine, Jiangsu Hengrui Medicine Co Ltd, Jiangsu Hengrui Pharmaceuticals.